Abstract
Immunohistochemical staining is widely used to identify opioid receptors in specific cell types or anatomical structures throughout the nervous system. Opioid receptors are not restricted to the central nervous system, but are also present in peripheral sensory neurons, where their activation exerts analgesic effects without inducing centrally mediated side effects. Here, we describe immunohistochemical analysis of opioid receptors in the peripheral sensory neuron cell bodies, along the axons and their peripheral endings in the hind paw skin, as well as in the spinal cord, under naïve and sciatic nerve damage conditions in mice. Moreover, we consider the current debate on the specificity of antibodies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Zollner C, Stein C (2007) Opioids. Handb Exp Pharmacol 177:31–63
Zhang X, Bao L, Arvidsson U et al (1998) Localization and regulation of the delta-opioid receptor in dorsal root ganglia and spinal cord of the rat and monkey: evidence for association with the membrane of large dense-core vesicles. Neuroscience 82:1225–1242
Minami M, Maekawa K, Yabuuchi K et al (1995) Double in situ hybridization study on coexistence of mu-, delta- and kappa-opioid receptor mRNAs with preprotachykinin A mRNA in the rat dorsal root ganglia. Brain Res Mol Brain Res 30:203–210
Li JL, Ding YQ, Li YQ et al (1998) Immunocytochemical localization of mu-opioid receptor in primary afferent neurons containing substance P or calcitonin gene-related peptide. A light and electron microscope study in the rat. Brain Res 794:347–352
Mousa SA, Cheppudira BP, Shaqura M et al (2007) Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain. Brain 130:502–513
Hassan AH, Ableitner A, Stein C et al (1993) Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience 55:185–195
Li JL, Kaneko T, Mizuno N (1996) Effects of peripheral nerve ligation on expression of mu-opioid receptor in sensory ganglion neurons: an immunohistochemical study in dorsal root and nodose ganglion neurons of the rat. Neurosci Lett 214:91–94
Kondo I, Marvizon JC, Song B et al (2005) Inhibition by spinal mu- and delta-opioid agonists of afferent-evoked substance P release. J Neurosci 25:3651–3660
Zollner C, Shaqura MA, Bopaiah CP et al (2003) Painful inflammation-induced increase in mu-opioid receptor binding and G-protein coupling in primary afferent neurons. Mol Pharmacol 64:202–210
Stein C, Machelska H (2011) Modulation of peripheral sensory neurons by the immune system: implications for pain therapy. Pharmacol Rev 63:860–881
Guan Y, Johanek LM, Hartke TV et al (2008) Peripherally acting mu-opioid receptor agonist attenuates neuropathic pain in rats after L5 spinal nerve injury. Pain 138:318–329
Kabli N, Cahill CM (2007) Anti-allodynic effects of peripheral delta opioid receptors in neuropathic pain. Pain 127:84–93
Obara I, Przewlocki R, Przewlocka B (2004) Local peripheral effects of mu-opioid receptor agonists in neuropathic pain in rats. Neurosci Lett 360:85–89
Obara I, Parkitna JR, Korostynski M et al (2009) Local peripheral opioid effects and expression of opioid genes in the spinal cord and dorsal root ganglia in neuropathic and inflammatory pain. Pain 141:283–291
Labuz D, Machelska H (2013) Stronger antinociceptive efficacy of opioids at the injured nerve trunk than at its peripheral terminals in neuropathic pain. J Pharmacol Exp Ther 346:535–544
Labuz D, Schmidt Y, Schreiter A et al (2009) Immune cell-derived opioids protect against neuropathic pain in mice. J Clin Invest 119:278–286
Michel MC, Wieland T, Tsujimoto G (2009) How reliable are G-protein-coupled receptor antibodies? Naunyn Schmiedebergs Arch Pharmacol 379:385–388
Scherrer G, Imamachi N, Cao YQ et al (2009) Dissociation of the opioid receptor mechanisms that control mechanical and heat pain. Cell 137:1148–1159
Jositsch G, Papadakis T, Haberberger RV et al (2009) Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor gene-deficient mice. Naunyn Schmiedebergs Arch Pharmacol 379:389–395
Schmidt Y, Gavériaux-Ruff C, Machelska M (2013) μ-Opioid receptor antibody reveals tissue-dependent specific staining and increased neuronal μ-receptor immunoreactivity at the injured nerve trunk in mice. PLoS One 8:e79099
Rigaud M, Gemes G, Barabas ME et al (2008) Species and strain differences in rodent sciatic nerve anatomy: implications for studies of neuropathic pain. Pain 136:188–201
Couchman JR (2009) Commercial antibodies: the good, bad, and really ugly. J Histochem Cytochem 57:7–8
Karaji AG, Reiss D, Matifas A et al (2011) Influence of endogenous opioid systems on T lymphocytes as assessed by the knockout of mu, delta and kappa opioid receptors. J Neuroimmune Pharmacol 6:608–616
Saper CB (2005) An open letter to our readers on the use of antibodies. J Comp Neurol 493:477–478
Acknowledgements
This work was supported by the Deutsche Forschungsgemeinschaft grant (MA 2437/1-4; H.M).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Schmidt, Y., Machelska, H. (2015). Immunohistochemical Analysis of Opioid Receptors in Peripheral Tissues. In: Spampinato, S. (eds) Opioid Receptors. Methods in Molecular Biology, vol 1230. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1708-2_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1708-2_12
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1707-5
Online ISBN: 978-1-4939-1708-2
eBook Packages: Springer Protocols